Abstract-Spinal cord injuries in rats were experimentally produced by compressing
Thyrotropin-releasing hormone (TRH) was originally identified as the substance that causes the release of thyrotropin and prolactin from the pituitary gland (1). TRH has many other actions on the central nervous system (2, 3) and has been used in the treatment of several neurological and psychiatric disorders (4-10). Faden and collaborators (11) have shown that a 4-hour intravenous infusion of TRH starting 1 hour or even 24 hours after traumatic spinal cord injury improves the ex tent of the neurologic recovery in cats. Ail' and collaborators (12) have shown that TRH ad ministration improves clinical parameters in patients with spinal cord injury, both chronic and stable cases. TRH has therefore been re ceiving a great deal of attention because of its possible use as pharmacotherapy for spinal cord injury. Although the neurologic out come-improving effect of TRH administered as late as 24 hours after spinal cord injury is noteworthy (13), TRH treatment starting 24 hours after injury has not been studied in detail except in cats (11).
The aim of the current work is to reconfirm the neurologic outcome-improving effect of TRH treatment starting 24 hours after spinal cord injury using another species, model (14) and administration method to study the dose dependency of TRH's effect, and to compare the relative effect of two TRH dosing sched ules.
Materials and Methods
Animals: Male Wistar rats weighing about 300 g were used. They were kept under con stant environmental conditions (24±1 °C and a regular 12-hour light/dark cycle), given food and water ad libitum, and were housed in groups of 4. Surgical procedures and postoperative care: A midline longitudinal incision was made into the skin of the back under sodium pentobarbitone (30 mg/kg, i.p.) anesthesia, the fascia was cut along the midline, and the dorsal surface of the spinal column was ex posed from T10 to T12 by paramedian in cision into the paraspinal muscles. The spinous process at the eleventh thoracic (T1 1 ) vertebra was dissected, and a small burr hole was made at the center of the dissected sur face of the vertebra. A stainless steel screw (2 mm in diameter and 2.8 mm in length) was implanted into the burr hole made just above the dura mater, and then the incision was sutured. On the following day, rats showing no neurologic dysfunction were anesthetized by ether inhalation, and the sutures were cut to expose the head of the screw. The spinal cord was compressed by inserting the screw as far as possible. The screw was left in place for 60 minutes. Following the removal of the screw, the incision was resutured. Rats having urinary incontinence were housed individual ly, and any urine wetting the external skin was washed away daily with warm water, and the area was dried with a paper towel. Neurologic symptoms and scoring: The main neurologic symptoms caused by com pression-induced spinal cord injury were motor deficits, sensory deficits, and urinary incontinence. Neurologic scores (NS) of 0-5 based on both motor and sensory deficits, were defined as follows: 0: no spontaneous movement of the hindlimbs and no withdrawal response upon tail pinching, including avoid ance movements by forelimbs, biting of clamps or vocalization; 1: no spontaneous movement of the hindlimbs but showing a withdrawal response upon tail pinching, in cluding avoidance movement of the forelimbs, biting of clamps or vocalization; 2: barely perceptible coordinated movement of the hindlimbs and forelimbs; 3: well coordinated movement of the hindlimbs and forelimbs, but no weight bearing by four limbs; 4: able to walk with weight bearing by all four limbs, but with an ataxic gait; 5: normal walking. Urinary incontinence was judged by wetness around the external genitalia due to urine. An inves tigator who was unaware of each individual animal's treatment evaluated the neurologic functions 24 hours and 2, 3, 4, 5, 6, 7, 8, 10, and 14 days after removal of the screws. Days required for the increase in the NS to a value greater than the initial NS of 1 were also recorded.
Administration of TRH: The rats with an NS of 1 twenty-four hours after cord injury started receiving subcutaneous injections of TRH (thyrotropin-releasing hormone tartrate, Takeda) or saline. The injections were given once (9:00 AM) or twice (9:00 AM and 3:00 PM) daily for 7 consecutive days. Saline or TRH dissolved in saline was injected in a volume of 1 ml/kg just after neurologic scoring.
Analysis of data: NSs of the animals in the saline-treated control group were compared with those of the animals in the TRH-treated groups utilizing the non-parametric Mann Whitney U-test (two-tailed). Differences in the incidence of urinary incontinence were compared utilizing Fisher's exact probability tests (two-tailed). Other differences were compared utilizing Dunnett's multiple range test (two-tailed) following analysis of vari ance (ANOVA).
Results
The main results of the spinal cord injury produced in rats by compression at the level of the T11 vertebra using stainless steel screws were motor deficits of the hindlimbs, sensory deficits of the hindlimbs and tail, and urinary incontinence.
Eighty-two percent of the animals with an NS of 1 twenty-four hours after injury showed urinary incon tinence. All the animals used survived more than 14 days after the spinal cord injury.
Effect of once daily administration of TRH on the neurologic deficits in rats with spinal cord injury: As shown in Table 1 , the mean number of post-injury days required for the increase in the NS in the rats with spinal cord injury that were treated with saline and TRH 5, 15, and 45 mg/kg once daily for 7 con secutive days starting 24 hours after injury was 5.7, 4.0, 3.9, and 3.0, respectively, in dicating that TRH had a significant dose related accelerating effect on the increase in the NS to a value greater than the initial score of 1 (F(3,52)=3.70, P<0.05). The accelera tion of the recovery rate in the TRH, 45 mg/ kg-treated group was significant when com pared to the saline-treated control (T=3.26, P<0.01). The median and individual NSs for the group treated with saline and those Table 1 . Number of days required for TRH administered once or twice daily to increase the neurologic score (NS) in rats with spinal cord injury to a score higher than the initial score of 1 Fig. 1 . Effect of TRH (5, 15, and 45 mg/kg/day, s.c., once daily for 7 consecutive days starting 24 hours after injury) on neurologic recovery from thoracic spinal cord compression-induced spinal cord injury in rats. Columns and circles represent median and individual values, respectively. *P<0.05, **P<0.01, compared to the saline-treated control group (Mann-Whitney's U-test, two-tailed).
treated with TRH at 5, 15, and 45 mg/kg treated group at 3, 5, 7, and 14 days post injury are shown in Fig. 1 . TRH had an ac celerating effect on the neurologic recovery after spinal cord injury. There was a signifi cant difference between the saline-treated control group and the TRH, 45 mg/kg treated group at each post-injury observation from day 3 to day 14 post-injury. As shown in Fig. 2A , a recovery-accelerating effect of once daily treatment with TRH was also observed with respect to the urinary incontinence, and the reduction in the incidence of urinary in continence was significant in the TRH, 45 mg/kg-treated group when compared to the saline-treated control group from day 4 to day 14 post-injury. Effect of twice daily administration of TRH on the neurologic deficits in rats with spinal cord injury: As shown in Table 1 , the mean number of post-injury days required for the increase in the NS in spinal cord-injured rats that were treated with saline and TRH at 2.5, 7.5 and 22.5 mg/kg twice daily for 7 consecutive days starting 24 hours after in jury was 4.4, 3.5, 3.2, and 3.0, respectively, indicating that TRH had a significant dose dependent accelerating effect on the increase in the NS to a value greater than the initial score of 1 (F(3,52)=3.86, P<0.05).
The re covery accelerating effect in the TRH, 7.5 mg/ kg x 2 (T=2.76, P l----0.05) and 22.5 mg/kg x 2 (T=3 .09, P<0.01)-treated groups was significant when compared to the saline treated group. The median and individual NSs for the saline and TRH, 2.5, 7.5, and 22.5 mg/ kg x 2-treated groups at 3, 5, 7, and 14 days post-injury are shown in Fig. 3 . There were significant differences between the saline treated control group and the TRH, 7.5 mg/ kg x 2-treated group from day 5 to day 7, and between the saline-treated control group and the TRH, 22.5 mg/kg x 2-treated group from day 5 to day 14 post-injury. As shown in Fig.  2B , a dose-related recovery-accelerating effect of twice daily treatment with TRH was observed with respect to urinary incontinence, and the reductions in the incidence in the TRH, 7.5 and 22.5 mg/kg x 2-treated groups were significant when compared to the saline group from day 4 to day 14 and from day 3 to day 14 post-injury, respectively. Comparison of the relative effect of once and twice daily repeated treatment with TRH on the neurologic recovery: Total NS, ob tained by the summation of the NSs from 9 observations (from day 2 to day 14 post injury), in the groups which were treated once and twice daily are shown in Fig. 4 . The me dian total NS in both saline-treated control groups was 19, indicating that the severity of the motor and sensory deficits in the two con trol groups was almost the same. The median total NSs in the groups that were treated once and twice daily with 15 mg/kg/day of TRH were 23 and 24.5, respectively; and there was a significant difference between the control group and the group treated twice daily with 15 mg/kg/day of TRH. On the other hand, the median total NSs in the groups that were treated once and twice daily with 45 mg/kg/ day of TRH were almost the same. In addition, while the mean number of days required for 45 mg/kg/day of TRH administered once and twice daily to elevate the NS above the initial NS of 1 was 3.0 in both cases, these numbers for 1 5 mg/kg/day of TRH administered once and twice daily were 3.9 and 3.2, respectively (Table 1 ). This was also true for the reducing effect of TRH on the incidence of urinary incontinence (Fig. 2) . 
Discussion
The present study demonstrated the ac celerating effect of TRH on the sensory-motor recovery after thoracic spinal cord compres sion-induced injury in rats when it is ad ministered subcutaneously once or twice daily for 7 consecutive days starting 24 hours after injury. This accelerating effect was dose dependent, and the minimum effective dose for once and twice daily treatment was 45 mg/ kg/day and 7.5 mg/kg x 2/day, respectively. Moreover, this is the first study to demon strate a reducing effect of TRH on the inci dence of urinary incontinence, one of the main neurologic signs seen after spinal cord injury in the present model.
The median total NS for the animals that were treated twice daily with 15 mg/kg/day of TRH, which is the intermediate daily dose in the present study, was higher than that for the animals that were treated once daily with the same daily dose of TRH. On the other hand, those in the groups that were treated once and twice daily with 45 mg/kg/day of TRH, which is the highest dose, were almost the same. In addition, the mean days required for 45 mg/kg/day of TRH administered once and twice daily to elevate the NS above the initial NS of 1 was 3.0 in both cases, while that for 15 mg/kg/day of TRH administered twice daily was smaller than that in the group that was treated once daily with the same daily dose of TRH. Thus, it is suggested that a TRH administration method that exposes the animal to TRH more frequently may be pre ferable when treatment with TRH begins 24 hours after spinal cord injury and the dose of TRH is intermediate.
In addition, our pre liminary study showed that continuous ad ministration of TRH, 15 mg/kg/day, for a week using an osmotic mini-pump caused a significant acceleration of the neurologic recovery in rats with an NS of 1 twenty-four hours after spinal cord injury (T. Hashimoto et al., unpublished). Faden and collaborators (11) first showed that intravenous infusion of TRH (2 mg/kg bolus, followed by 2 mg/kg/hour for 4 hours, totally 10 mg/kg) 24 hours after cervical spinal cord injury that is induced by weight drop improves the extent of the motor re covery in cats. The present study reconfirmed the neurologic outcome-improving effect of TRH treatment starting 24 hours after spinal cord injury. However, Faden et al. have dem onstrated this effect of TRH only with a 4 hour infusion, while our administration meth od was once or twice daily injection of TRH. In pilot experiments, we failed to demonstrate a significant neurologic outcome-improving effect with a single subcutaneous dose of TRH (45 mg/kg) 24 hours after injury using the present model, but with once daily subcu taneous treatment with TRH (45 mg/kg/day) for 7 days starting 24 hours after injury, we have succeeded in demonstrating a significant effect. Thus, in the present study, we adopted repeated treatment with TRH for 7 days.
A number of pathophysiological factors have been proposed as the cause of the post traumatic necrosis seen in spinal cord injury following the initial insult (13, 15). It has been reported that TRH antagonizes the behavioral changes induced by 3-endorphin (16, 17), one of the proposed pathophysiological fac tors (18), and reverses the hypotension in duced by an arachidonic acid metabolite, leukotriene D4 (19), also one of the patho physiological factors (20) . Accordingly, it is conceivable that the neurologic recovery accelerating effect of TRH shown in the present study is a result of the antagonistic action of TRH on the changes induced by the pathophysiological factors mentioned above. However, it has been assumed that the ir reversible disruption of the spinal cord tissue caused by the above factors terminates within 8 hours after spinal cord injury (21) . In addi tion, our preliminary data (T. Hashimoto et al., unpublished) have shown that repeated ad ministration of naloxone HCI (45 mg/kg/day, s.c., once daily for 7 consecutive days starting 24 hours after injury), which improves neu rologic outcome by acute treatment (22) as TRH does (11, 23), did not show any accel erating effect on the neurologic recovery in rats with spinal cord compression injury. Thus, it is difficult to assume that the acceleration of the neurologic recovery by treatment with TRH starting 24 hours after injury is due to its antagonistic action on these factors, although the ameliorating effect of acutely adminis tered TRH (23) may be due to the mech anisms described previously. 
